A detailed history of Clark Estates Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Clark Estates Inc holds 1,475,648 shares of STTK stock, worth $1.7 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
1,475,648
Previous 1,475,648 -0.0%
Holding current value
$1.7 Million
Previous $5.7 Million 9.59%
% of portfolio
1.34%
Previous 1.46%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$2.5 - $4.72 $11,875 - $22,420
-4,750 Reduced 0.32%
1,475,648 $4.34 Million
Q4 2022

Feb 08, 2023

BUY
$1.96 - $3.26 $270,397 - $449,743
137,958 Added 10.28%
1,480,398 $3.4 Million
Q3 2022

Nov 15, 2022

BUY
$2.6 - $5.52 $3.49 Million - $7.41 Million
1,342,440 New
1,342,440 $3.63 Million
Q2 2022

Aug 08, 2022

BUY
$2.7 - $4.59 $287,550 - $488,835
106,500 Added 8.58%
1,347,640 $5.47 Million
Q1 2022

May 13, 2022

BUY
$4.22 - $8.89 $1.81 Million - $3.82 Million
429,500 Added 52.92%
1,241,140 $5.29 Million
Q4 2021

Feb 14, 2022

BUY
$8.36 - $21.08 $20,900 - $52,699
2,500 Added 0.31%
811,640 $6.91 Million
Q3 2021

Nov 12, 2021

BUY
$17.57 - $28.95 $407,624 - $671,640
23,200 Added 2.95%
809,140 $16.5 Million
Q2 2021

Aug 10, 2021

SELL
$24.14 - $37.68 $17.2 Million - $26.8 Million
-711,164 Reduced 47.5%
785,940 $22.8 Million
Q1 2021

May 14, 2021

BUY
$27.92 - $52.5 $19.5 Million - $36.6 Million
697,492 Added 87.23%
1,497,104 $43.8 Million
Q4 2020

Feb 09, 2021

BUY
$19.0 - $57.61 $15.2 Million - $46.1 Million
799,612 New
799,612 $41.9 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $48.7M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Clark Estates Inc Portfolio

Follow Clark Estates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark Estates Inc with notifications on news.